Category : Healthcare and Pharmaceuticals | Published at : February-2020 | Delivery Format : PDF | Status: Published | Pages : 190
The global assisted reproductive technology (ART) market is expected to grow at a CAGR of around 8.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 44.59 Bn by 2026.
Assisted reproductive technology is fertility treatment in which the eggs of women ovaries are removed with surgery and combining them with sperm in a laboratory, and return them into the women body or another women body.The main functions of assisted reproductive technology (ART) are to treat infertility in men and women and helps individual to conceive a child.Based on technology, different types of assisted reproductive technology (ART)such as in-vitro fertilization, artificial insemination-intrauterine insemination, and frozen embryo replacement are used.
Market Dynamics
The growth of the assisted reproductive technology (ART) market is primarily driven by growing number of cases of infertility,government support for infertility processes,and increase in chronic diseases across the globe and technological advancements in assisted reproductive technology (ART). Furthermore, increase in number of new treatment by biotechnology and pharmaceutical key players and expanding base of various dieses patients worldwide, is estimated to boost the market growth. Moreover, changing lifestyles of consumers across developed countries, growing pharmaceutical and medical industry, technological advancement and increase in the number of applications are expected to create opportunities for the manufacturers in the global market over the forecast period. However, high cost of treatment and lower success rate of treatment are expected to hamper the growth of the global assisted reproductive technology (ART)market in the coming years.
By technology, in-vitro fertilization (IVF) technology segment dominated the assisted reproductive technology (ART)market
The In-vitro fertilization (IVF) technology segment accounted for approximately 34% of the share in the global assisted reproductive technology (ART) market in 2018.Increase in demand for successful treatment and increase in advancement in technology, growing demand for successful conceiving of child through this technology and cost-effectively coupled with rising male infertility is further expected to raise segment over the forecast period.
By end-use, fertility clinics segment dominated the assisted reproductive technology (ART)market
The fertility clinics development segment accounted for approximately 32% of the share in the global assisted reproductive technology (ART)market in 2018. Growing demand for assisted reproductive technology (ART)for treatment by consumers and growing investment for ART development and initiatives for development of ART in clinics is further expected to raise segment over the forecast period.Owing to its growing number of clinics in developing countries, presence of specialized services in fertility clinics, and supportive government initiatives for assisted reproductive technology (ART) in research and development centres further grows the demand for assisted reproductive technology (ART)in fertility clinics during the forecast period.
The market research study on “Assisted Reproductive Technology (ART)Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”,offers a detailed insight into the global assisted reproductive technology (ART)market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global assisted reproductive technology (ART)market, its technology, end use, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global assisted reproductive technology (ART)market size, and segment markets by technology, end use, and geography along with the information on companies operating in the market. The assisted reproductive technology (ART)market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
In 2018, North America dominated the regional market with a maximum market share
North America accounted for the high market share of the assisted reproductive technology (ART)market and the region is also expected to maintain its dominance over the forecast period. The region is experiencing the maximum growth owing to the rapid consumption of assisted reproductive technology (ART) in treatment, presence of assisted reproductive technology (ART)companies, favorable reimbursement policies, and increase in awareness of people. High research and development in biotechnology and pharmaceutical, development and launching of new technology, and developed healthcare infrastructure in the North America region are one of the key factors driving the consumption of assisted reproductive technology (ART)in this region.Moreover, highly skilled surgeons, growing number of laboratory and research centers in key countries such as US and Canada are also propelling the growth of assisted reproductive technology (ART)in the North America region.Europe is followed by the North America region in the assisted reproductive technology (ART)market.
Asia-Pacific is expected to hold the highest CAGR in the global market during the forecast period. The growing pharmaceutical and biotechnology and industry increase in innovation and development in assisted reproductive technology (ART), and growing successful rate and growing awareness of ART, are expected to enhance the market growth in the global assisted reproductive technology (ART)market during the forecast.
The players profiled in the report include Vitro Life, Cooper Surgical Inc., Genea Limited, Cook Medical, and Hamilton Thorne, IVFtech ApS, Irvine scientific, Merck, Nidacon International AB, OvaScience Inc., and Thermo Fisher Scientific, Inc. among others. The companies are involved in mergers and acquisitions and new product development for expanding their market share and also for gaining competitive advantages over its competitors.
Market Segmentation
Market By Technology
- In-Vitro Fertilization
- Artificial Insemination-Intrauterine Insemination
- Frozen Embryo Replacement
Market By End-Use
- Hospitals
- Fertility Clinics
- Others
Market By Geography
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
Assisted reproductive technology is fertility treatment in which the eggs of women ovaries are removed with surgery and combining them with sperm in a laboratory, and return them into the women body or another women body.
In-vitro fertilization, artificial insemination-intrauterine insemination, and frozen embryo replacement are the three types of assisted reproductive technology.
Factors such as growing number of cases of infertility, government support for infertility processes,and increase in chronic diseases across the globe restrain the assisted reproductive technology market growth.
According to Acumen Research and Consulting, the assisted reproductive technology market value is anticipated to be worth around US$ 44.59 billion in 2026.
The assisted reproductive technology market is anticipated to grow over 8.6% CAGR during the forecast period 2019 to 2026.
North America held maximum share in 2018 for assisted reproductive technology market.
Asia Pacific is projected to grow at a fast pace during forecast period in the assisted reproductive technology market.
